H
erein we describe four cases of intra-abdominal infections due to Comamonas kerstersii. In all of them, C. kerstersii was isolated from free fluid in the abdominal cavity. In three cases, a perforated appendix was the source of intra-abdominal infection; in the other case, it was a sigmoid colon perforation. C. kerstersii was always isolated in conjunction with other pathogens. Only one patient had an underlying disease. In all cases, the clinical evolution was favorable. The main clinical features of each case are presented in Table 1 .
After 48 h of incubation at 35°C and in ambient air, growth of a nonfermenting Gram-negative bacillus was observed in all abdominal fluid cavity cultures. The colonies grew to a diameter of 1.5 mm on blood agar and on nutrient agar in ambient air. They were white, smooth, and nonadherent, and they had entire edges.
The organisms were identified as C. kerstersii by using standard biochemical tests (1) and according to the scheme proposed by Wauters et al. (2, 3) . This scheme is centered around three enzymatic activities, oxidase, trypsin (benzyl-arginine aminopeptidase), and pyrrolidonyl aminopeptidase. Additionally, biochemical tests, such as determination of acid production from glucose, colistin and desferrioxamine susceptibility, urease production, motility, nitrate reduction, growth at 42°C, and tyrosine hydrolysis, were required to make the final identification ( Table 2 ). The isolates were also analyzed on a Vitek 2 compact system (bioMéri-eux) using a GN colorimetric identification card and with API 20NE version 6.0 (numerical profiles were interpreted using the APILAB software, version 3.3.3 [bioMérieux]). The Vitek 2 and API 20NE results are summarized in Table 3 . Identification was also carried out by using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) (Bruker Daltonik), which resulted in spectral scores of 2.022, 2.066, 2.097, and 2.251 for the four C. kerstersii isolates (4).
The results of differential biochemical tests on our isolates, different species of Comamonas, and other nonsaccharolytic microorganisms are shown in Table 2 .
Because of the rarity of this pathogen, PCR amplification of the 16S rRNA was performed in order to confirm the species. PCR products of the 16S rRNA gene were obtained with the primers described by Weisburg et al. (5) and by using the Taq DNA polymerase according to the manufacturer's specifications (Promega). Sequencing of the 1.4-kb PCR product was performed on both DNA strands at the Macrogen, Inc., Seoul, South Korea, sequencing facility. The obtained sequences of the 4 isolates were analyzed using the BLAST V2.0 software (http://www.ncbi.nlm.nih.gov /BLAST/). The result showed a 99% identity with the sequences corresponding to the 16S RNA ribosomal gene of Comamonas kerstersii strain LMG 5323 (GenBank accession no. AJ430348.1); there was a 2-base mismatch between the 4 isolate sequences and Comamonas kerstersii strain LMG 5323. In order to obtain a more discriminatory sequence and also confirm the obtained result, we amplified the gyrB gene (coding for subunit beta of DNA gyrase), which has been shown to resolve phylogenetic relationships in various bacterial groups (6) . A PCR product of around 420 bp was obtained using the primers described by Tayeb et al. (6) . In all cases, sequence analysis revealed 98% identity with the gyrB sequence of Comamonas kerstersii strain CIP 107987, which corresponds to 8 mismatches between the compared sequences (GenBank accession no. EU024199), 92% identity with the gyrB sequence of Comamonas aquatica strain CIP 107986 (GenBank accession no. EU024201), and 90% identity with the gyrB sequence of Comamonas testosteroni strain CNB-2 (GenBank accession no. CP001220). These results confirm the species identification.
The antibiotic susceptibility test was performed using the Vitek 2 system employing panel AST-082 (GNS susceptibility card). The MIC results were interpreted using CLSI categories (7). MIC ranges for different antibiotics were as follows (g/ml): ampicillin, Յ2 to 16; ampicillin-sulbactam, Յ2; piperacillin-tazobactam, Յ4; cephalothin, Յ2; cefoxitin, Յ4 to 8; cefotaxime, Յ1; ceftazidime, Յ1 to 2; cefepime, Յ1; imipenem, Յ1; meropenem, Յ0.25; gentamicin, Յ2 to 4; amikacin, 16; ciprofloxacin, Յ0.25 to Ն4; colistin, Յ0.5 to 1; and trimethoprim-sulfamethoxazole, Յ2 to 4. C. kerstersii was highly susceptible to antibiotics, except for one of the isolates, which showed resistance to ciprofloxacin.
The genus Comamonas was originally created in 1985, and it included a single species, Comamonas terrigena (8) . In 1987, Pseudomonas acidovorans and Pseudomonas testosteroni were reclassified as members of the genus Comamonas. Comamonas acidovorans was subsequently reclassified as Delftia acidovorans (9) . Comamonas terrigena actually comprises three genotypically separate groups: Comamonas terrigena, Comamonas aquatica, and Comamonas kerstersii (2).
Barbaro et al. have reported the tendency of C. testosteroni to cause peritoneal cavity infections and perforated appendixes as specific anatomic defects resulting from the infection (10). They identified 10 cases of infections due to this microorganism in patients hospitalized at a single metropolitan hospital during a 3-year period. In 6 of them, C. testosteroni was isolated from the peritoneal cavity; in 5 cases, a perforated appendix was the source of intra-abdominal infection. In the four remaining cases, the infection corresponded to bacteremia (two cases), genitourinary tract infection, and central nervous system infection (10). However, it is possible that the isolates described by Barbaro et al. were identified as C. testosteroni because C. kerstersii is not found in the 
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a ϩ, positive; Ϫ, negative; S, susceptible; R, resistant; ND, not done. Data are from references 1, 2, and 3. Vitek database, which is the identification source used by these authors. Gul et al. also have referred to the association of C. testosteroni with a perforated appendix. They were the first to report an acute case of bacteremia due to this organism in Turkey in a 22-year-old man with a perforated appendix (11) . However, again, this microorganism might have been C. kerstersii, since it was identified only by phenotypic methods. Our work is the first to demonstrate the association of C. kerstersii with peritonitis secondary to appendix rupture.
In the literature, infections due to C. kerstersii may be underestimated because in previously published cases of Comamonas infection, identification of isolates has been achieved only by phenotypic methods, which do not allow differentiation among species of the genus (10) (11) (12) (13) (14) (15) (16) .
Very few members of the Comamonadaceae family have been reported to cause infections in humans. However, most reported cases are due to Delftia acidovorans or to C. testosteroni. Both organisms are known to produce ocular infections (15, 17, 18) , bacteremia, and central-line-associated bloodstream infections in patients with any underlying disease, such as malignancy, liver disease (11, 13, 14, 16, (19) (20) (21) (22) , and endocarditis (23, 24), among others. There is only one report of human infection due to C. terrigena in the literature. It was a case of acute bacterial endocarditis which responded appropriately to antibiotic treatment (25) .
C. kerstersii should be differentiated from other Comamonas species and from other related organisms that also reduce nitrates and do not assimilate or acidify sugars, such as Pseudomonas alcaligenes. Sensitivity to deferoxamine, nonuse of testosterone, a negative pyrrolidone arylamidase test, growth at 42°C, and a positive tyrosine hydrolysis test differentiate C. kerstersii from other Comamonas species, while its sensitivity to desferrioxamine and lack of trypsin activity differentiate it from P. alcaligenes (Table 2) .
We emphasize that the isolation of C. kerstersii from free fluid in the abdominal cavity and a perforated appendix are indications of intra-abdominal infection. Also, we highlight the need to request polyphasic identification to obtain definitive identification.
Nucleotide sequence accession numbers. The obtained sequences for the C. kerstersii rRNA and gyrB genes have been submitted to GenBank under accession no. KC714046 and KC714047, respectively.
